Dean Petkanas Neuropathix, Inc. (NPTX) insider trading activity

Dean Petkanas is Chief Executive Officer of NEUROPATHIX, INC.. Currently has a direct ownership of 23.1 Million shares of NPTX, which is worth approximately $0. The most recent transaction as insider was on Jun 13, 2022, when has been sold 400,000 shares (Common Stock) at a price of $0.02 per share, resulting in proceeds of $8,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.1M

0% 3M change

0% 12M change

Total Value Held $0

DEAN PETKANAS Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 13 2022	SELL Bona fide gift	$8,000 $0.02 p/Share	400,000 Reduced 1.7%	23,149,029 Common Stock
Jun 09 2022	SELL Open market or private sale	$4,763 $0.02 p/Share	238,164 Reduced 1.0%	23,559,029 Common Stock
Jun 08 2022	SELL Open market or private sale	$437 $0.02 p/Share	21,836 Reduced 0.09%	23,797,193 Common Stock
Jun 07 2022	SELL Open market or private sale	$1,000 $0.02 p/Share	50,000 Reduced 0.21%	23,819,029 Common Stock
Jun 06 2022	SELL Open market or private sale	$200 $0.02 p/Share	10,000 Reduced 0.04%	23,869,029 Common Stock
May 31 2022	SELL Open market or private sale	$900 $0.03 p/Share	30,000 Reduced 0.13%	23,879,029 Common Stock
May 27 2022	SELL Open market or private sale	$1,500 $0.03 p/Share	50,000 Reduced 0.21%	23,909,029 Common Stock
May 26 2022	SELL Open market or private sale	$3,000 $0.03 p/Share	100,000 Reduced 0.42%	23,959,029 Common Stock

Dean Petkanas

Chief Executive Officer

Doylestown, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NPTX shares.

Notify only if

Value

Insider Trading

Get notified when an Neuropathix, Inc. insider buys or sells NPTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to NEUROPATHIX, INC.

Track Activities on NPTX

Account